Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otenabant in obese adults
NCT00375401Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Oct 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of otenabant in obesity, sponsored by Pfizer. Started Oct 2006; status: terminated.
02
Drugs
otenabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00375401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375401.